Table 4.
ANOVA analyses of CD14+ HLA-G+ monocytes.
| Model | Groups | Mean difference (95% CI) | SMD (95% CI) | Partial Eta2 | P value$ |
|---|---|---|---|---|---|
| Crude | Critical vs Moderate/Severe | −17.06 (−22.59; −11.54) | −2.09 (−2.77; −1.41) | 0.439 | 0.0000 |
| Critical vs Healthy control | −6.79 (−12.37; −1.20) | −0.83 (−1.40; −0.25) | – | – | |
| Moderate/Severe vs Healthy control | 10.27 (4.69; 15.85) | 1.26 (0.65; 1.86) | – | – | |
| Adjusted for age | Critical vs Moderate/Severe | −17.22 (−22.94; −11.51) | −2.04 (−2.70; −1.35) | 0.439 | 0.0000 |
| Critical vs Healthy control | −6.51 (−12.63; −0.38) | −0.76 (−1.32; −0.18) | – | – | |
| Moderate/Severe vs Healthy control | 10.71 (4.86; 16.57) | 1.26 (0.65; 1.86) | – | – | |
| Adjusted for gender | Critical vs Moderate/Severe | −17.53 (−23.18; −11.88) | −2.10 (−2.78; −1.42) | 0.449 | 0.0000 |
| Critical vs Healthy control | −7.20 (−12.98; −1.42) | −0.86 (−1.43; −0.28) | – | – | |
| Moderate/Severe vs Healthy control | 10.32 (4.61; 16.04) | 1.24 (0.63; 1.83) | – | – |